Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL

(2016) Philippe Rousselot et al.   BLOOD

Meet the neighbors: Mapping local protein interactomes by proximity-dependent labeling with BioID

(2016) Renata Varnaitė et al.   PROTEOMICS

Intramolecular hydrophobic interactions are critical mediators of STAT5 dimerization

(2016) Dirk Fahrenkamp et al.   Scientific Reports

2016 update of the PRIDE database and its related tools

(2015) Juan Antonio Vizcaíno et al.   NUCLEIC ACIDS RESEARCH

Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS

(2013) Markku Varjosalo et al.   NATURE METHODS

Diverging fates of cells of origin in acute and chronic leukaemia

(2012) Boris Kovacic et al.   EMBO Molecular Medicine

BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia

(2012) Oliver Hantschel et al.   Nature Chemical Biology

Rapid and Reproducible Single-Stage Phosphopeptide Enrichment of Complex Peptide Mixtures: Application to General and Phosphotyrosine-Specific Phosphoproteomics Experiments

(2011) Arminja N. Kettenbach et al.   ANALYTICAL CHEMISTRY

High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia

(2011) W. Warsch et al.   BLOOD

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

(2011) Carlo Gambacorti-Passerini et al.   JNCI-Journal of the National Cancer Institute

Global Phosphoproteomics Reveals Crosstalk Between Bcr-Abl and Negative Feedback Mechanisms Controlling Src Signaling

(2011) L. Rubbi et al.   Science Signaling

How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia

(2010) A. K. Fielding   BLOOD

Stat5 is indispensable for the maintenance ofbcr/abl-positive leukaemia

(2010) Andrea Hoelbl et al.   EMBO Molecular Medicine

The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization

(2010) B Titz et al.   ONCOGENE

Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions

(2009) C G Mullighan et al.   LEUKEMIA

Charting the molecular network of the drug target Bcr-Abl

(2009) M. Brehme et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association Between Imatinib-Resistant BCR-ABL Mutation-Negative Leukemia and Persistent Activation of LYN Kinase

(2008) Ji Wu et al.   JNCI-Journal of the National Cancer Institute

Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases

(2008) K De Keersmaecker et al.   LEUKEMIA